Schistosomiasis japonica: The DALYs recaptured

PLoS Neglected Tropical Diseases

Volumn 2, Issue 3, 2008, Pages

  King, Charles H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISCHISTOSOMAL AGENT;

ANEMIA; COGNITIVE DEFECT; DEATH; DEVELOPING COUNTRY; DIARRHEA; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; EPILEPSY; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MALNUTRITION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MORBIDITY; NOTE; OUTCOME ASSESSMENT; PARASITE TRANSMISSION; PATHOGENESIS; PHILIPPINES; POVERTY; PROBABILITY; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SNAIL; TREMATODE; TROPICAL DISEASE; TROPICAL MEDICINE; WATER CONTAMINATION; WATER QUALITY; WATER SUPPLY; WORM EXPULSION; ANIMAL; DECISION TREE; PARASITOLOGY; PATHOPHYSIOLOGY; QUALITY ADJUSTED LIFE YEAR; SCHISTOSOMIASIS JAPONICA; STATISTICAL MODEL;

ANIMALS; DECISION TREES; MODELS, STATISTICAL; QUALITY-ADJUSTED LIFE YEARS; SCHISTOSOMIASIS JAPONICA;

EID: 48949118039     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000203     Document Type: Note

References (28)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development systemfatic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. Kirigia JM (1997) Economic evaluation in schistosomiasis: using the delphi technique to assess effectiveness. Acta Trop 64: 175-190.
3. Finkelstein JL, Schleinitz M, Carabin H, McGarvey ST (2008) Decision-model estimation of the age-specific disability weight for schistosomiasis japonica. PLoS Negl Trop Dis 2: e158. doi:10.1371/ journa.pntd.0000158.
4. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
5. Sturrock RF (2001) The schistosomes and their intermediate hosts. In: Mahmoud AAF, ed. Schiatosomiasis. London: Imperial College Press. pp 7-83.
6. Useh MF, Ejezie GC (1999) Modification of behaviour and attitude in the control of schistosomiasis. 1. Observations on water-contact patterns and perception of infection. Ann Trop Med Parasitol 93: 711-720.
7. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke M, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
8. Bergquist NR, Leonardo LR, Mitchell GF (2005) Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21: 112-117.
9. Warren KS (1982) Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis 4: 715-726.
10. Murray CJL, Lopez AD, eds (1996) The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (Massachusetts): Harvard School of Public Health/World Bank. 990 p.
11. Tanner M (1989) Evaluation of public health impact of schistosomiasis. Trop Med Parasitol 40: 143-148.
12. King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illness. In press.
13. Olveda RM (2001) Disease in schitosomiasis japonica. In: Mahmoud AAF, ed. Schistosomiasis. London: Imperial College Press. pp 361-390.
14. Jia T-W, Zhou X-N, Wang X-H, Utzinger J, Steinmann P, et al. (2007) Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ 85: 458-465.
15. Kirigia JM (1998) Economic evaluation in schistosomiasis: valuation of health states preferences. A research note. Health Econ 7: 551-556.
16. Moore DV, Sandground RH (1956) The relative egg producing capacity of Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg 5: 831-840.
17. Richter J, Correia Dacal AR, Vergetti Siqueira JG, Poggensee G, Mannsmann U, et al, (1998) Sonograpbic prediction of variccal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Trop Med Int Health 3: 728-735.
18. Ouma JH, King CH, Muchiri EM, Mungai P, Koech DK, et al. (2005) Late benefits 10-18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya. American Journal of Tropical Medicine and Hygiene 73: 359-364.
19. Olveda RK Daniel BL, Ramirez BD, Aligui GD, Acosta LP, et al. (1996) Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J Infect Dis 174: 163-172.
20. King CH, Bertino A-M (2008) Asymmetries of poverty: why global burden of disease DALY valuations significantly underestimate the burden of neglected tropical diseases, PLoS Negl Trop Dis 2: e209. doi:10.1371/ journal.pntd.0000209.
21. Bridges J, Stewart M, King M, van Gool K (2002) Adapting portfolio theory for the evaluation of multiple investments in health with a multiplicative extension for treatment synergies. Eur J Health Econ 3: 47-53.
22. Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLos Negl Trop Dis 1: e114. doi:10.1371/journal.pntd.0000114.
23. Singer BH, Ryff CD (2007) Neglected tropical diseases, neglected data sources, and neglected issues. PLoS Negl Trop Dis 1: e104. doi:10.1371/ journal.pntd.0000104.
24. Michaud CM, Gordon WS, Reich MR (2004) The global burden of disease due to schistosomiasis. Cambridge (Massachusetts): Harvard Center for Population and Development Studies, Harvard School of Public Health. pp 1-41.
25. Jamison DT (2006) Investing in health. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, et al. eds. Disease control priorities in developing countries. Washington (D.C.): Oxford University Press and The World Bank. pp 3-34.
26. Gwatkin DR, Guillot M, Heuveline P (1999) The burden of disease among the global poor. Lancet 354: 586-589.
27. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, et al. (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 3: e102. doi:10.1371/journal.pmed.0030102.
28. Hotez P, Ottesen E, Fenwick A, Molyneux D (2006) The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv Exp Med Biol 582: 23-33.